JP2024508969A5 - - Google Patents
Info
- Publication number
- JP2024508969A5 JP2024508969A5 JP2023554812A JP2023554812A JP2024508969A5 JP 2024508969 A5 JP2024508969 A5 JP 2024508969A5 JP 2023554812 A JP2023554812 A JP 2023554812A JP 2023554812 A JP2023554812 A JP 2023554812A JP 2024508969 A5 JP2024508969 A5 JP 2024508969A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163158539P | 2021-03-09 | 2021-03-09 | |
| US63/158,539 | 2021-03-09 | ||
| US202163172818P | 2021-04-09 | 2021-04-09 | |
| US63/172,818 | 2021-04-09 | ||
| US202163265179P | 2021-12-09 | 2021-12-09 | |
| US63/265,179 | 2021-12-09 | ||
| PCT/IB2022/052120 WO2022190010A1 (en) | 2021-03-09 | 2022-03-09 | Novel darpin based cd33 engagers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024508969A JP2024508969A (ja) | 2024-02-28 |
| JPWO2022190010A5 JPWO2022190010A5 (https=) | 2025-03-18 |
| JP2024508969A5 true JP2024508969A5 (https=) | 2025-03-18 |
Family
ID=80933410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554812A Pending JP2024508969A (ja) | 2021-03-09 | 2022-03-09 | 新規のＤＡＲＰｉｎに基づくＣＤ３３エンゲージャ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240317852A1 (https=) |
| EP (1) | EP4304730A1 (https=) |
| JP (1) | JP2024508969A (https=) |
| AU (1) | AU2022231913A1 (https=) |
| CA (1) | CA3211248A1 (https=) |
| WO (1) | WO2022190010A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298168A (en) | 2020-05-14 | 2023-01-01 | Molecular Partners Ag | Multispecific proteins |
| IL305677A (en) | 2021-03-09 | 2023-11-01 | Molecular Partners Ag | Novel darpin based multi-specific t-cell engagers |
| WO2024251628A1 (en) * | 2023-06-06 | 2024-12-12 | Molecular Partners Ag | Recombinant cd16a binding proteins and their use |
| WO2025163082A1 (en) * | 2024-01-31 | 2025-08-07 | Molecular Partners Ag | Dll3-specific binding constructs and their use in radiotherapy |
| WO2025181039A1 (en) | 2024-03-01 | 2025-09-04 | Molecular Partners Ag | Therapeutic combinations comprising a multi-specific t cell engager |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9400088D0 (sv) | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| DE60140474D1 (de) | 2000-09-08 | 2009-12-24 | Univ Zuerich | Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten |
| US20040175756A1 (en) | 2001-04-26 | 2004-09-09 | Avidia Research Institute | Methods for using combinatorial libraries of monomer domains |
| US20050053973A1 (en) | 2001-04-26 | 2005-03-10 | Avidia Research Institute | Novel proteins with targeted binding |
| US20050048512A1 (en) | 2001-04-26 | 2005-03-03 | Avidia Research Institute | Combinatorial libraries of monomer domains |
| WO2005063815A2 (en) | 2003-11-12 | 2005-07-14 | Biogen Idec Ma Inc. | Fcϝ receptor-binding polypeptide variants and methods related thereto |
| US20060008844A1 (en) | 2004-06-17 | 2006-01-12 | Avidia Research Institute | c-Met kinase binding proteins |
| CA2700391A1 (en) | 2007-09-24 | 2009-04-02 | University Of Zuerich | Designed armadillo repeat proteins |
| EP3785735A1 (en) | 2008-11-03 | 2021-03-03 | Molecular Partners AG | Binding proteins inhibiting the vegf-a receptor interaction |
| EP2332994A1 (en) * | 2009-12-09 | 2011-06-15 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Trispecific therapeutics against acute myeloid leukaemia |
| TWI510246B (zh) | 2010-04-30 | 2015-12-01 | Molecular Partners Ag | 抑制ｖｅｇｆ－ａ受體交互作用的經修飾結合性蛋白質 |
| DK2643349T3 (da) | 2010-11-26 | 2019-11-25 | Molecular Partners Ag | Designede repeat-proteiner, der binder til serumalbumin |
| CA2877584A1 (en) | 2012-06-28 | 2014-01-03 | Molecular Partners Ag | Designed ankyrin repeat proteins binding to platelet-derived growth factor |
| EP2738180A1 (en) | 2012-11-30 | 2014-06-04 | Molecular Partners AG | Binding proteins comprising at least two binding domains against HER2. |
| EP2789630A1 (en) | 2013-04-09 | 2014-10-15 | EngMab AG | Bispecific antibodies against CD3e and ROR1 |
| US11453708B2 (en) | 2013-05-31 | 2022-09-27 | Molecular Partners Ag | Designed ankyrin repeat proteins binding to hepatocyte growth factor |
| AU2016240220B2 (en) | 2015-04-02 | 2019-11-21 | Molecular Partners Ag | Designed ankyrin repeat domains with binding specificity for serum albumin |
| US10717772B2 (en) | 2016-09-22 | 2020-07-21 | Molecular Partners Ag | Recombinant binding proteins targeting HER2 and serum albumin, and their uses |
-
2022
- 2022-03-09 WO PCT/IB2022/052120 patent/WO2022190010A1/en not_active Ceased
- 2022-03-09 CA CA3211248A patent/CA3211248A1/en active Pending
- 2022-03-09 AU AU2022231913A patent/AU2022231913A1/en not_active Abandoned
- 2022-03-09 US US18/281,156 patent/US20240317852A1/en active Pending
- 2022-03-09 JP JP2023554812A patent/JP2024508969A/ja active Pending
- 2022-03-09 EP EP22712451.8A patent/EP4304730A1/en active Pending